Tamara A. Favorito - Sep 22, 2021 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
Director
Signature
/s/ Anthony Scott Praill, attorney-in-fact for Tamara A. Seymour
Stock symbol
KTRA
Transactions as of
Sep 22, 2021
Transactions value $
$0
Form type
4
Date filed
9/22/2021, 08:37 PM
Previous filing
Aug 18, 2021
Next filing
May 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTRA Options (Right to Buy) Award $0 +35K $0.00 35K Sep 22, 2021 Common Stock 35K $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on October 22, 2021.